Indivior PharmaceuticalsINDV
13F holders, Q4 2025 (December 31)12holders +11
11new positions
0sold out
$35.88avg. 13F price*
At the end of Q4 2025, 12 institutions reported holding Indivior Pharmaceuticals Inc. (INDV) in their 13F filings, up 11 from Q3 2025. 11 opened new positions and 0 sold out. The largest holders were Madison Avenue Partners, LP ($225.3M), Driehaus Capital Management LLC ($71.8M) and Navellier & Associates Inc. ($4.1M).
- Company
- Indivior Pharmaceuticals Inc.
- CUSIP
- 45579U109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $305.7M |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 8,519,158 shares bought, net +8,519,158 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Madison Avenue Partners, LP | 9.68% | New | 6,280,502 | $225.3M |
| Driehaus Capital Management LLC | 0.49% | New | 2,000,339 | $71.8M |
| Navellier & Associates Inc. | 0.46% | New | 114,904 | $4.1M |
| AWM Investment Company, Inc. | 0.26% | New | 75,605 | $2.7M |
| Globeflex Capital L P | 0.17% | New | 30,280 | $1.1M |
| Catalyst Funds Management Pty Ltd | 0.13% | New | 16,180 | $581K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 734 | $26K |
| SBI Securities Co., Ltd. | 0.00% | New | 250 | $9K |
| Rothschild Investment LLC | 0.00% | New | 206 | $7K |
| Essential Partners LLC | 0.00% | Add +1850.0% | 78 | $3K |
| Bare Financial Services, Inc | 0.00% | New | 63 | $2K |
| Arax Advisory Partners | 0.00% | New | 21 | $753 |
"% of holder's portfolio" is INDV's weight in each manager's 13F, not the share of Indivior Pharmaceuticals Inc. the manager owns.